Clinical Trials Logo

Aphakia clinical trials

View clinical trials related to Aphakia.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06389643 Completed - Aphakia Clinical Trials

Comparison of Safety and Efficacy of Four-Point Scleral Intraocular Lens Fixation and Yamane Techniques

Start date: March 19, 2021
Phase: N/A
Study type: Interventional

Comparison of safety and efficacy of two scleral fixation intraocular lens (IOL) methods of four-point scleral fixation ( Akreos AO60) and the Yamane technique (AcrySof MA60AC)

NCT ID: NCT05852470 Completed - Aphakia Clinical Trials

Evaluation of Clareon Vivity/Vivity Toric

Start date: May 23, 2023
Phase: N/A
Study type: Interventional

This study seeks to generate clinical data from subjects previously implanted with the Clareon Vivity/Clareon Vivity Toric IOLs or Clareon Monofocal/Clareon Toric IOLs. This study will assess key performance endpoints to support clinical benefits with model-specific data.

NCT ID: NCT05796674 Completed - Astigmatism Clinical Trials

Clareon IOL Retrospective Data Collection

Start date: August 18, 2023
Phase:
Study type: Observational

The purpose of this study is to provide real world evidence (RWE) on the performance of the Clareon ultraviolet absorbing (UVA) intraocular lenses (IOLs) to support the overall body of evidence on the Clareon IOL family.

NCT ID: NCT05481125 Completed - Cataract Clinical Trials

Clareon Toric vs Eyhance Toric

Start date: October 10, 2022
Phase: N/A
Study type: Interventional

The primary purpose of this study is to compare the Clareon/Clareon Toric Intraocular Lenses (IOLs) to the Eyhance/Eyhance Toric IOLs in binocular Best Corrected Distance Visual Acuity (BCDVA) at 3 months postoperative.

NCT ID: NCT04755231 Completed - Presbyopia Clinical Trials

Post-Market Clinical Study of the PanOptix Intraocular Lens (IOL) in a Chinese Population

Start date: April 19, 2021
Phase: N/A
Study type: Interventional

The primary objective of this clinical study is to assess the clinical performance of the PanOptix IOL in a Chinese population.

NCT ID: NCT04542525 Completed - Aphakia Clinical Trials

Clinical Investigation of an AcrySof IQ PanOptix Toric Intraocular Lens

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of the TFNT20 low cylinder power intraocular lens when implanted in the eye to replace the natural lens following cataract removal.

NCT ID: NCT04528069 Completed - Aphakia Clinical Trials

Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Toric IOL in an Asian Population

Start date: November 16, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the clinical performance of the ACRYSOF® IQ PanOptix® Toric Trifocal intraocular lens (IOL) when implanted in the eye following cataract removal in an Asian population.

NCT ID: NCT04330001 Completed - Presbyopia Clinical Trials

Exploratory Clinical Study for Techniques Associated With the Fluid Accommodating IOL

Start date: December 28, 2020
Phase: N/A
Study type: Interventional

The purpose of this clinical study is to assess the repeatability of objective refraction using auto refraction on subjects bilaterally implanted (implanted in both eyes) with the Fluid Accommodating IOL (FAIOL).

NCT ID: NCT04098367 Completed - Aphakia Clinical Trials

Clinical Investigation of the AcrySof IQ Vivity Extended Vision Intraocular Lens (IOL)

Start date: November 18, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the visual disturbance profile of an intraocular lens (IOL) using nondiffractive optics, the VIVITY IOL, to two diffractive IOLs in subjects requiring bilateral cataract surgery. IOLs are implantable medical devices intended for long-term use over the lifetime of the cataract patient.

NCT ID: NCT04005651 Completed - Clinical trials for Aphakia, Postcataract

Safety and Efficacy of a Trifocal Intraocular Lens (IOL) POD L GF in Comparison With a Multifocal and a Monofocal IOL

Start date: May 30, 2019
Phase: N/A
Study type: Interventional

The objectives of the Post-Market Follow-up (PMCF) clinical investigation are to determine the safety and performance of a hydrophobic trifocal intraocular lens POD L GF in comparison with two comparator lenses: another multifocal intraocular lens (Johnson & Johnson TECNIS Symfony® Extended Range of Vision IOL); and a monofocal intraocular lens (Alcon AcrySof® IQ Monofocal IOL) through one year of post-operative assessments.